Clinical trials query results

From Health Canada


New search



Medical condition:
MAJOR DEPRESSIVE DISORDER
Medical condition:
ADULT FEMALE,ADULT MALE
Drug name:
PSILOCYBIN
Protocol title:
EVALUATING THE EFFECT OF LENGTH OF TIME ON SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) ON THE RESPONSE TO PSILOCYBIN-ASSISTED THERAPY IN INDIVIDUALS WITH MILD-MODERATE MAJOR DEPRESSIVE DISORDER (MDD)
Sponsor name:
CYBIN THERAPEUTICS INC.
Date of no objection letter:
2022-01-28
Control number:
260009
Trial status:
CLOSED
Date study completed:
2024-02-05
Date modified: